Form D · Biotechnology

Drug Delivery Company, LLC

Salisbury, MD · CIK 0001935521

Offering snapshot reported Aug 19, 2024 · SEC filing

Reported sold
$675K
Indefinite offering
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 12, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$338K$675KAug 19, 2024: $75,000.00Aug 19, 2024Aug 19, 2024: $675,000.00Aug 19, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$75,000 → $675,000
  • Reported investors1 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 19, 2024Initial$75,000No comparison1SEC filing
Aug 19, 2024Amendment$675,000$600,000vs Aug 19, 20243SEC filing
Apr 10, 2023InitialYet to sellNo comparison0SEC filing
Jun 28, 2022InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-521842

Source: Form D, filed Aug 19, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Benner Director, Executive, Promoter
Steven Cohen Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6511 Deer Pointe Drive
Salisbury, MD, 21804